These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 21767996)

  • 1. Science please.
    Zdeblick TA
    Spine J; 2011 Jul; 11(7):686; author reply 687-90. PubMed ID: 21767996
    [No Abstract]   [Full Text] [Related]  

  • 2. Another complication associated with rhBMP-2?
    Kang JD
    Spine J; 2011 Jun; 11(6):517-9. PubMed ID: 21612984
    [No Abstract]   [Full Text] [Related]  

  • 3. Yet another reason for improving approval and surveillance processes for health technologies.
    Kovacs FM; Olabe J; Urrútia G; Zamora J; Bagó J; Alvarez-Galovich L; Abraira V;
    Spine J; 2011 Aug; 11(8):800-1; author reply 801. PubMed ID: 21778121
    [No Abstract]   [Full Text] [Related]  

  • 4. An evolving perception of the risk of rhBMP-2 use for anterior spinal interbody fusions.
    Smoljanovic T; Bojanic I
    Spine J; 2011 Jun; 11(6):520-1. PubMed ID: 21612986
    [No Abstract]   [Full Text] [Related]  

  • 5. Acknowledging the elephant in the room: conflict of interest in industry-sponsored clinical research.
    Hart RA
    Spine J; 2011 Aug; 11(8):703-4. PubMed ID: 21925414
    [No Abstract]   [Full Text] [Related]  

  • 6. Commentary: Retrograde ejaculation and the use of rhBMP-2 for anterior lumbar interbody fusion: what does the evidence say to surgeons and to patients?
    Mroz TE; Abdullah KG; Benzel EC
    Spine J; 2012 Oct; 12(10):891-3. PubMed ID: 23199820
    [No Abstract]   [Full Text] [Related]  

  • 7. Retrograde ejaculation after anterior lumbar interbody fusion using rhBMP-2: a cohort controlled study.
    Carragee EJ; Mitsunaga KA; Hurwitz EL; Scuderi GJ
    Spine J; 2011 Jun; 11(6):511-6. PubMed ID: 21612985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Editorial: Recombinant human bone morphogenetic protein-2.
    Shaffrey CI; Smith JS
    J Neurosurg Spine; 2013 Feb; 18(2):109-10; discussion 110-1. PubMed ID: 23198758
    [No Abstract]   [Full Text] [Related]  

  • 9. Vertebral body osteolysis after minimal-access transforaminal interbody fusion.
    Lehman RA
    Spine J; 2011 Jun; 11(6):581-2. PubMed ID: 21729806
    [No Abstract]   [Full Text] [Related]  

  • 10. Symptomatic ectopic intracanal ossification after transforaminal lumbar interbody fusion with rhBMP-2.
    Lehman RA; Kang DG
    Spine J; 2012 Jun; 12(6):530-1. PubMed ID: 22682741
    [No Abstract]   [Full Text] [Related]  

  • 11. A biologic without guidelines: the YODA project and the future of bone morphogenetic protein-2 research.
    Carragee EJ; Baker RM; Benzel EC; Bigos SJ; Cheng I; Corbin TP; Deyo RA; Hurwitz EL; Jarvik JG; Kang JD; Lurie JD; Mroz TE; Oner FC; Peul WC; Rainville J; Ratliff JK; Rihn JA; Rothman DJ; Schoene ML; Spengler DM; Weiner BK
    Spine J; 2012 Oct; 12(10):877-80. PubMed ID: 23199819
    [No Abstract]   [Full Text] [Related]  

  • 12. Important considerations on bone morphogenetic protein-2 and neuroinflammation.
    Heggeness MH
    Spine J; 2011 Jun; 11(6):506. PubMed ID: 21729800
    [No Abstract]   [Full Text] [Related]  

  • 13. Editorial: No increased risk?
    Hadley MN
    J Neurosurg Spine; 2013 Feb; 18(2):122-4; discussion 124-5. PubMed ID: 23231360
    [No Abstract]   [Full Text] [Related]  

  • 14. Retrograde ejaculation after anterior lumbar interbody fusion with and without bone morphogenetic protein-2 augmentation: a 10-year cohort controlled study.
    Comer GC; Smith MW; Hurwitz EL; Mitsunaga KA; Kessler R; Carragee EJ
    Spine J; 2012 Oct; 12(10):881-90. PubMed ID: 23098617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Folly of FDA-approval studies for bone morphogenetic protein.
    Mirza SK
    Spine J; 2011 Jun; 11(6):495-9. PubMed ID: 21729798
    [No Abstract]   [Full Text] [Related]  

  • 16. Complications with recombinant human bone morphogenetic protein-2 in posterolateral spine fusion associated with a dural tear.
    Glassman SD; Gum JL; Crawford CH; Shields CB; Carreon LY
    Spine J; 2011 Jun; 11(6):522-6. PubMed ID: 20598649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Promoting fusion in minimally invasive lumbar interbody stabilization with low-dose bone morphogenic protein-2--but what is the cost?
    Mannion RJ; Nowitzke AM; Wood MJ
    Spine J; 2011 Jun; 11(6):527-33. PubMed ID: 20739225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reply to "A critical review of recombinant human bone morphogenetic protein-2 trials in spinal surgery: emerging safety concerns and lessons learned".
    Dimar JR; Glassman SD; Burkus JK; Pryor PW; Hardacker JW; Carreon LY
    Spine J; 2011 Nov; 11(11):1082-3; author reply 1083-6. PubMed ID: 22078853
    [No Abstract]   [Full Text] [Related]  

  • 19. Re: A critical review of recombinant human bone morphogenetic protein-2 trials in spinal surgery: emerging safety concerns and lessons learned.
    Woo EJ
    Spine J; 2011 Aug; 11(8):804; author reply 804-5. PubMed ID: 21925424
    [No Abstract]   [Full Text] [Related]  

  • 20. Exposing conflicts of interest and complications of rhBMP-2.
    Chi JH
    Neurosurgery; 2011 Oct; 69(4):N21-2. PubMed ID: 21900807
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.